المؤلفون: Gonzalez-Angulo AM, Chen H, Karuturi MS, Chavez-Macgregor M, Tsavachidis S, Meric-Bernstam F, Do KA, Hortobagyi GN, Thompson PA, Mills GB, Bondy ML, Blumenschein GR Jr, Gonzalez-Angulo, Ana M, Chen, Huiqin, Karuturi, Meghan S, Chavez-MacGregor, Mariana, Tsavachidis, Spyrus, Meric-Bernstam, Funda, Do, Kim-Anh, Hortobagyi, Gabriel N

المصدر: Cancer (0008543X); Jan2013, Vol. 119 Issue 1, p7-15, 9p

مصطلحات موضوعية: AMINO acids, BREAST tumors, CELL physiology, GENES, PHOSPHOTRANSFERASES, PROGNOSIS, RESEARCH funding, TUMOR markers, GENOTYPES

المؤلفون: Raghavendra AS; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jennings K; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Guerra G; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Karuturi MS; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

المصدر: The oncologist [Oncologist] 2024 Jul 17. Date of Electronic Publication: 2024 Jul 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

المؤلفون: Blum JL; Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. jlblum@att.net., DiCristo C; Pfizer Inc, New York, NY, USA., Gordon D; Munson Medical Center, Traverse City, MI, USA., Karuturi MS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Oubre D; Ponchartrain Cancer Center, Hammond, LA, USA., Jepsen E; Novant Health Cancer Institute, Winston-Salem, NC, USA., Cuevas J; St. Louis Cancer Care, St. Louis, MO, USA., Lakhanpal S; Saint Vincent's Birmingham, Birmingham, AL, USA., Montelongo MZ; ICON plc, Blue Bell, PA, USA., Zhang Z; Pfizer Inc, La Jolla, CA, USA., Cappelleri JC; Pfizer Inc, Groton, CT, USA., Wang Y; Pfizer Inc, New York, NY, USA., Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Feb; Vol. 203 (3), pp. 463-475. Date of Electronic Publication: 2023 Oct 30.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology , Piperazines* , Pyridines*, Aged ; Humans ; Male ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Prospective Studies ; Quality of Life ; Receptor, ErbB-2/metabolism

المؤلفون: Karuturi MS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: MSKaruturi@mdanderson.org., Cappelleri JC; Pfizer Inc, Groton, CT, USA., Blum JL; Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA., Patel K; CARTI Cancer Center, Little Rock, AR, USA., Telivala B; Cancer Specialists of North Florida, Jacksonville, FL, USA., McCune S; Northwest Georgia Oncology Centers, Marietta, GA, USA., Cuevas JD; St. Louis Cancer Care, St. Louis, MO, USA., Lakhanpal S; Saint Vincent's Birmingham, Birmingham, AL, USA., Montelongo MZ; ICON plc, Blue Bell, PA, USA., Wang Y; Pfizer Inc, New York, NY, USA., Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rocque GB; University of Alabama at Birmingham, Birmingham, AL, USA.

المصدر: Journal of geriatric oncology [J Geriatr Oncol] 2024 Jan; Vol. 15 (1), pp. 101670. Date of Electronic Publication: 2023 Dec 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101534770 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-4076 (Electronic) Linking ISSN: 18794068 NLM ISO Abbreviation: J Geriatr Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Antineoplastic Agents*/therapeutic use, Aged ; Female ; Humans ; Activities of Daily Living ; Functional Status ; Prospective Studies ; Piperazines ; Pyridines

المؤلفون: Haddad TC; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Suman VJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., D'Assoro AB; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Carter JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Giridhar KV; Department of Oncology, Mayo Clinic, Rochester, Minnesota., McMenomy BP; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Santo K; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Mayer EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Karuturi MS; Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, Texas., Morikawa A; Department of Medicine, University of Michigan, Ann Arbor., Marcom PK; Department of Medicine, Duke University Cancer Institute, Durham, North Carolina., Isaacs CJ; Department of Medicine, Georgetown University, Washington, DC., Oh SY; Department of Medical Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York., Clark AS; Department of Medicine, University of Pennsylvania, Philadelphia., Mayer IA; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Keyomarsi K; Department of Experimental Radiation Oncology, MD Anderson Cancer Center, Houston, Texas., Hobday TJ; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Peethambaram PP; Department of Oncology, Mayo Clinic, Rochester, Minnesota., O'Sullivan CC; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Leon-Ferre RA; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Liu MC; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Ingle JN; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Goetz MP; Department of Oncology, Mayo Clinic, Rochester, Minnesota.

المصدر: JAMA oncology [JAMA Oncol] 2023 Jun 01; Vol. 9 (6), pp. 815-824.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology, Humans ; Female ; Middle Aged ; Fulvestrant ; Estrogen Receptor alpha ; Aurora Kinase A/therapeutic use ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Mitin N; Sapere Bio, Research Triangle Park, NC, USA., Nyrop KA; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Strum SL; Sapere Bio, Research Triangle Park, NC, USA., Knecht A; Sapere Bio, Research Triangle Park, NC, USA., Carey LA; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Reeder-Hayes KE; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Claire Dees E; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Jolly TA; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kimmick GG; Duke University School of Medicine, Durham, NC, USA., Karuturi MS; MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Reinbolt RE; Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Speca JC; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., O'Hare EA; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Muss HB; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. hyman_muss@med.unc.edu.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. hyman_muss@med.unc.edu.

المصدر: NPJ breast cancer [NPJ Breast Cancer] 2022 Sep 08; Vol. 8 (1), pp. 103. Date of Electronic Publication: 2022 Sep 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

المؤلفون: Kalra M; Division of Hematology/Oncology, Department of Medicine, Indiana University Health Ball Memorial Hospital, Fishers, IN, United States., Henry E; Division of Hematology/Oncology, Department of Medicine, Loyola University Stritch School of Medicine, Maywood, IL, United States., McCann K; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Beverly Hills, CA, United States., Karuturi MS; Division of Hematology/Oncology, Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Bustamante Alvarez JG; Division of Hematology/Oncology, Department of Medicine, West Virginia University, Morgantown, WV, United States., Parkes A; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin, Madison, WI, United States., Wesolowski R; Division of Hematology/Oncology, Department of Medicine, Ohio State University, Columbus, OH, United States., Wei M; Division of Hematology/Oncology, Department of Medicine, University of Utah, Utah City, UT, United States., Mougalian SS; Department of Radiation/Oncology, Yale University School of Medicine, New Haven, CT, United States., Durm G; Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States., Qin A; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States., Schonewolf C; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States., Trivedi M; Division of Hematology/Oncology, Department of Medicine, Herbert-Irving Comprehensive Cancer Center, Columbia University, New York, NY, United States., Armaghani AJ; Division of Hematology/Oncology, Department of Medicine, Moffitt Cancer Center University of South Florida, Tampa, FL, United States., Wilson FH; Department of Radiation/Oncology, Yale University School of Medicine, New Haven, CT, United States., Iams WT; Division of Oncology, Department of Medicine, Vanderbilt University, Nashville, TN, United States., Turk AA; Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States., Vikas P; Division of Hematology/Oncology, Department of Medicine, University of Iowa, Iowa City, IA, United States., Cecchini M; Department of Radiation/Oncology, Yale University School of Medicine, New Haven, CT, United States., Lubner S; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin, Madison, WI, United States., Pathak P; Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States., Spencer K; Division of Hematology/Oncology, Department of Medicine, Rutgers University Cancer Institute of New Jersey, New Brunswick, NJ, United States., Koshkin VS; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Beverly Hills, CA, United States., Labriola MK; Division of Hematology/Oncology, Department of Medicine, Duke University, Durham, NC, United States., Marshall CH; Division of Oncology, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States., Beckermann KE; Division of Oncology, Department of Medicine, Vanderbilt University, Nashville, TN, United States., Sharifi MN; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin, Madison, WI, United States., Bejjani AC; Division of Hematology/Oncology, Department of Medicine, Veterans Health Administration Greater Los Angeles Health System, Los Angeles, CA, United States., Hotchandani V; Mednet Inc, New York, NY, United States., Housri S; Mednet Inc, New York, NY, United States., Housri N; Department of Radiation/Oncology, Yale University School of Medicine, New Haven, CT, United States.

مؤلفون مشاركون: theMednet.org NCI-CCC Tumor Board Program Collaborative Group; Mednet Inc, New York, NY, United States.

المصدر: JMIR cancer [JMIR Cancer] 2022 May 19; Vol. 8 (2), pp. e33859. Date of Electronic Publication: 2022 May 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101666844 Publication Model: Electronic Cited Medium: Print ISSN: 2369-1999 (Print) Linking ISSN: 23691999 NLM ISO Abbreviation: JMIR Cancer Subsets: PubMed not MEDLINE

المؤلفون: Karuturi MS; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: mskaruturi@mdanderson.org., Giordano SH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hoover DS; Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Volk RJ; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Housten AJ; Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, United States.

المصدر: Journal of geriatric oncology [J Geriatr Oncol] 2022 Mar; Vol. 13 (2), pp. 170-175. Date of Electronic Publication: 2021 Dec 23.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101534770 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-4076 (Electronic) Linking ISSN: 18794068 NLM ISO Abbreviation: J Geriatr Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy, Aged ; Aged, 80 and over ; Chemotherapy, Adjuvant ; Decision Making ; Decision Making, Shared ; Female ; Humans ; Qualitative Research ; Quality of Life

المؤلفون: Layman RM; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin H; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gutierrez Barrera AM; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Karuturi MS; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yam C; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Arun BK; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Cancer medicine [Cancer Med] 2022 Mar; Vol. 11 (6), pp. 1474-1483. Date of Electronic Publication: 2022 Feb 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/therapy, Chemotherapy, Adjuvant ; Female ; Humans ; Mutation ; Neoplasm Recurrence, Local/pathology

SCR Disease Name: Breast Cancer, Familial

المؤلفون: Nyrop KA; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA. kirsten_nyrop@med.unc.edu.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. kirsten_nyrop@med.unc.edu., Damone EM; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Deal AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Wheeler SB; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Charlot M; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Reeve BB; Duke University School of Medicine, Durham, NC, USA., Basch E; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Shachar SS; Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Carey LA; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Reeder-Hayes KE; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Dees EC; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Jolly TA; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kimmick GG; Duke University School of Medicine, Durham, NC, USA., Karuturi MS; MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Reinbolt RE; Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Speca JC; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA., Wood WA; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Muss HB; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Jan; Vol. 191 (2), pp. 409-422. Date of Electronic Publication: 2021 Nov 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy, Anthracyclines/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy ; Patient Reported Outcome Measures